Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Contribution of F-18 Fluoro-Deoxy-Glucose PET/CT (Positron Emission Tomography) to the Assessment of HCC (Hepato-cellular Carcinoma) Treatment Efficiency

NCT01322477 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT01322477
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01322477 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Contribution of F-18 Fluoro-Deoxy-Glucose PET/CT (Positron Emission Tomography) to the Assessment of HCC (Hepato-cellular Carcinoma) Treatment Efficiency
Lead sponsor
Hadassah Medical Organization
Phase
Observational
Overall status
Unknown status
Start date
Not reported
Completion date
Not reported
Enrollment
25
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma